latanoprost + brimonidine

Latanoprost + brimonidine is a fixed-dose combination ophthalmic drug used to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Latanoprost is a prostaglandin F2α analog that reduces intraocular pressure by increasing the outflow of aqueous humor through the uveoscleral pathway. Brimonidine is an alpha-2 adrenergic receptor agonist that lowers intraocular pressure by decreasing aqueous humor production and increasing uveoscleral outflow. The combination leverages complementary mechanisms to enhance efficacy in reducing intraocular pressure, which helps prevent optic nerve damage and vision loss associated with glaucoma[1][3][4][5][6][8].